I have written a number of articles on the effectiveness of hydroxychloroquine (HCQ) as a therapeutic for the prevention and early stage minimization of the impact of the Chicom flu. The following graph, organized by countries of use, indicates that it does work.
Note that the USA is in the “orange” category and is third from the left on the chart.
The USA case fatality rate is about twice that of those countries who employed HCQ from the beginning of the pandemic response. The most trusted data shown in this chart are from Israel and South Korea.
The USA case fatality rate is roughly equal to Japan. This is significant in that Japan is in the no HCQ category.
The USA case fatality rate is about a quarter that of France and about a third that of the UK, Italy, Belgium and the Netherlands. These countries are in the no HCQ category.
This next chart documents the Swiss experience with the use, elimination and then reuse of Hydroxychloroquine. It is reasonable proof the HCQ not only works but works well. It is obvious that the Swiss government made a bad political decision in eliminating HCQ use, realized the implications of that bad decision, and acted quickly to correct their mistake.
If these charts are accurate, then the American media and much of the political left has extensive blood on its hands for having ridiculed HCQ use.
Note: I have had difficulty validating the source of this data. So, I post it with a measure of caution and the hope that a commenter can pin down both source and accuracy.
